AOBiome LLC
11
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
82%
9 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis
Role: lead
A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis
Role: lead
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
Role: lead
Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis
Role: lead
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
Role: lead
Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris
Role: lead
A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea
Role: lead
A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
Role: lead
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.
Role: lead
Cosmetic Study of AO+Mist in Improving the Appearance of Skin Afflicted With Keratosis Pilaris
Role: lead
A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris
Role: lead
All 11 trials loaded